Drug Profile
Polymerised liposome vaccine delivery system
Alternative Names: OrasomeLatest Information Update: 28 Aug 2007
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 16 Jun 2000 Endorex has received an additional US patent for the Orasome delivery system
- 12 Jun 1998 Preclinical development for Undefined in USA (Parenteral)